{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:58:52Z","timestamp":1783699132602,"version":"3.55.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008731","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T18:18:27Z","timestamp":1510683507000},"page":"e8731","source":"Crossref","is-referenced-by-count":14,"title":["Complete remission and long-term survival of a patient with melanoma metastases treated with high-dose fever-inducing Viscum album extract"],"prefix":"10.1097","volume":"96","author":[{"given":"Paul G.","family":"Werthmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hintze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunver S.","family":"Kienle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-81-20210226","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/med.21404","article-title":"Metastatic melanoma: insights into the evolution of the treatments and future challenges: metastatic melanoma","volume":"37","author":"Millet","year":"2017","journal-title":"Med Res Rev"},{"key":"R2-81-20210226","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CMR.0b013e32832eabd5","article-title":"Spontaneous regression of metastases from melanoma: review of the literature","volume":"19","author":"Kalialis","year":"2009","journal-title":"Melanoma Res"},{"key":"R3-81-20210226","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00008390-199910000-00011","article-title":"Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer","volume":"9","author":"K\u00f6lmel","year":"1999","journal-title":"Melanoma Res"},{"key":"R4-81-20210226","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1523-1747.2002.00643.x","article-title":"Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study","volume":"119","author":"Pfahlberg","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R5-81-20210226","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ctrv.2014.06.012","article-title":"Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma","volume":"40","author":"McDermott","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"R8-81-20210226","doi-asserted-by":"crossref","first-page":"501796","DOI":"10.1155\/2012\/501796","article-title":"Fermented mistletoe extract as a multimodal antitumoral agent in gliomas","volume":"2012","author":"Podlech","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"R9-81-20210226","first-page":"2945","article-title":"Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity","volume":"29","author":"Elluru","year":"2009","journal-title":"Anticancer Res"},{"key":"R10-81-20210226","doi-asserted-by":"crossref","first-page":"23837","DOI":"10.1039\/C5RA27381A","article-title":"European Viscum album: a potent phytotherapeutic agent with multifarious phytochemicals, pharmacological properties and clinical evidence","volume":"6","author":"Singh","year":"2016","journal-title":"RSC Adv"},{"key":"R11-81-20210226","first-page":"103","article-title":"Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts","volume":"12","author":"Kienle","year":"2007","journal-title":"Eur J Med Res"},{"key":"R12-81-20210226","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/1534735410369673","article-title":"Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies","volume":"9","author":"Kienle","year":"2010","journal-title":"Integr Cancer Ther"},{"key":"R13-81-20210226","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1016\/j.ejca.2013.06.043","article-title":"Viscum album [L] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival","volume":"49","author":"Troger","year":"2013","journal-title":"Eur J Cancer"},{"key":"R14-81-20210226","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejca.2003.07.004","article-title":"Final results of the EORTC 18871\/DKG 80-1 randomised phase III trial","volume":"40","author":"Kleeberg","year":"2004","journal-title":"Eur J Cancer"},{"key":"R15-81-20210226","first-page":"38","article-title":"Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC\/AJCC Stage II and III) with a standardized fermented European Mistletoe (Viscum album L.) extract","volume":"55","author":"Augustin","year":"2005","journal-title":"Arzneimittelforschung"},{"key":"R17-81-20210226","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/acm.2007.6175","article-title":"Successful treatment of metastatic malignant melanoma with viscum album extract (Iscador\u00ae M)","volume":"13","author":"Kirsch","year":"2007","journal-title":"J Altern Complement Med"},{"key":"R18-81-20210226","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.eujim.2009.08.010","article-title":"Durable tumour responses following primary high-dose induction with mistletoe extracts: two case reports","volume":"1","author":"Orange","year":"2010","journal-title":"Eur J Integr Med"},{"key":"R19-81-20210226","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7453\/gahmj.2012.1.1.006","article-title":"Durable regression of primary cutaneous B-cell lymphoma following fever-inducing mistletoe treatment: two case reports","volume":"1","author":"Orange","year":"2012","journal-title":"Global Adv Health Med"},{"key":"R20-81-20210226","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.phymed.2012.11.001","article-title":"Durable response of cutaneous squamous cell carcinoma following high-dose peri-lesional injections of Viscum album extracts: a case report","volume":"20","author":"Werthmann","year":"2013","journal-title":"Phytomedicine"},{"key":"R21-81-20210226","doi-asserted-by":"crossref","first-page":"ii","DOI":"10.1136\/bcr-2013-203180","article-title":"Tumour response following high-dose intratumoural application of Viscum album on a patient with adenoid cystic carcinoma","volume":"2014","author":"Werthmann","year":"2014","journal-title":"BMJ Case Rep"},{"key":"R22-81-20210226","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1534735416649916","article-title":"Coley's lessons remembered: augmenting mistletoe therapy","volume":"15","author":"Orange","year":"2016","journal-title":"Integr Cancer Ther"},{"key":"R23-81-20210226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.bjc.6601463","article-title":"Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma","volume":"90","author":"Mabed","year":"2004","journal-title":"Br J Cancer"},{"key":"R24-81-20210226","first-page":"221","article-title":"Multicenter open labeled clinical study in advanced breast cancer patients. A preliminary report","volume":"11","author":"Mahfouz","year":"1999","journal-title":"J Egypt Nat Cancer Inst"},{"key":"R25-81-20210226","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1472-6882-11-72","article-title":"Safety of higher dosages of Viscum album L. in animals and humans: systematic review of immune changes and safety parameters","volume":"11","author":"Kienle","year":"2011","journal-title":"BMC Complement Altern Med"},{"key":"R27-81-20210226","doi-asserted-by":"crossref","first-page":"4628287","DOI":"10.1155\/2016\/4628287","article-title":"Intravenous mistletoe treatment in integrative cancer care: a qualitative study exploring the procedures, concepts, and observations of expert doctors","volume":"2016","author":"Kienle","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"R28-81-20210226","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/1534735416640091","article-title":"Individualized integrative cancer care in anthroposophic medicine: a qualitative study of the concepts and procedures of expert doctors","volume":"15","author":"Kienle","year":"2016","journal-title":"Integr Cancer Ther"},{"key":"R30-81-20210226","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00262-013-1455-1","article-title":"Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy","volume":"62","author":"Maletzki","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"R31-81-20210226","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/postgradmedj\/79.938.672","article-title":"Dr William Coley and tumour regression: a place in history or in the future","volume":"79","author":"Cann","year":"2003","journal-title":"Postgrad Med J"},{"key":"R32-81-20210226","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7453\/gahmj.2012.1.1.016","article-title":"Fever in cancer treatment: Coley's therapy and epidemiologic observations","volume":"1","author":"Kienle","year":"2012","journal-title":"Global Adv Health Med"},{"key":"R33-81-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s002620100216","article-title":"Fever and cancer in perspective","volume":"50","author":"Hobohm","year":"2001","journal-title":"Cancer Immunol Immunother"},{"key":"R34-81-20210226","first-page":"129","article-title":"Significant tumor reduction, improvement of pain and quality of life and normalization of sleeping patterns of cancer patients treated with a high dose of mistletoe","volume":"9","author":"Mahfouz","year":"1998","journal-title":"In: Annals of Oncology"},{"key":"R35-81-20210226","first-page":"497A","article-title":"The effect of a mistletoe preparation with defined lectin content in advanced hepatocellular carcinoma cases","volume":"48","author":"Eldorry","year":"2008","journal-title":"In: Hepatology"},{"key":"R36-81-20210226","doi-asserted-by":"crossref","first-page":"236310","DOI":"10.1155\/2014\/236310","article-title":"Safety of intravenous application of mistletoe (Viscum album L.) Preparations in oncology: an observational study","volume":"2014","author":"Steele","year":"2014","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T13:54:04Z","timestamp":1693230844000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711170-00081"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":31,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008731","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}